These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 30861137)
1. Practice patterns of reflux medication prescriptions in otolaryngology compared to other specialties. Luetzenberg FS; Jiang N Laryngoscope; 2020 Feb; 130(2):321-327. PubMed ID: 30861137 [TBL] [Abstract][Full Text] [Related]
2. Trends in acid suppressant drug prescriptions in primary care in the UK: a population-based cross-sectional study. Abrahami D; McDonald EG; Schnitzer M; Azoulay L BMJ Open; 2020 Dec; 10(12):e041529. PubMed ID: 33293322 [TBL] [Abstract][Full Text] [Related]
3. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014). Landi SN; Sandler RS; Pate V; Lund JL Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546 [TBL] [Abstract][Full Text] [Related]
4. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study. El-Serag HB; Fitzgerald S; Richardson P Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229 [TBL] [Abstract][Full Text] [Related]
5. National Trends for Medicare Prescriptions of Antireflux Medications. Fass OZ; Poels KE Gastroenterology; 2020 Jul; 159(1):378-380.e3. PubMed ID: 32222398 [No Abstract] [Full Text] [Related]
6. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital. Luo H; Fan Q; Xiao S; Chen K BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830 [TBL] [Abstract][Full Text] [Related]
7. Do recent reports about the adverse effects of proton pump inhibitors change providers' prescription practice? Al-Qaisi MT; Kahn A; Crowell MD; Burdick GE; Vela MF; Ramirez FC Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29873678 [TBL] [Abstract][Full Text] [Related]
8. Acid suppressants for managing gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants: a national survey. Bell JC; Schneuer FJ; Harrison C; Trevena L; Hiscock H; Elshaug AG; Nassar N Arch Dis Child; 2018 Jul; 103(7):660-664. PubMed ID: 29472195 [TBL] [Abstract][Full Text] [Related]
9. Implementation of a Guideline to Decrease Use of Acid-Suppressing Medications in the NICU. Angelidou A; Bell K; Gupta M; Tropea Leeman K; Hansen A Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29162657 [TBL] [Abstract][Full Text] [Related]
10. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications. Zhu LL; Xu LC; Chen Y; Zhou Q; Zeng S World J Gastroenterol; 2012 Jun; 18(24):3167-72. PubMed ID: 22791953 [TBL] [Abstract][Full Text] [Related]
11. Prescribing trends of proton pump inhibitors and histamine blockers among children in the United Kingdom (1998-2019): A population-based assessment. Masarwa R; Reynier P; Lefebvre C; Platt RW; Delaney JAC; Filion KB Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5752. PubMed ID: 38362652 [TBL] [Abstract][Full Text] [Related]
12. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists. Andrade SE; Gurwitz JH; Fish LS Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023 [TBL] [Abstract][Full Text] [Related]
13. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change. Ramser KL; Sprabery LR; Hamann GL; George CM; Will A J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274 [TBL] [Abstract][Full Text] [Related]
14. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study. Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985 [TBL] [Abstract][Full Text] [Related]
16. A practice-based approach for converting from proton pump inhibitors to less costly therapy. Lucas LM; Gerrity MS; Anderson T Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299 [TBL] [Abstract][Full Text] [Related]
17. Changing impact of gastroesophageal reflux in medical and otolaryngology practice. Altman KW; Stephens RM; Lyttle CS; Weiss KB Laryngoscope; 2005 Jul; 115(7):1145-53. PubMed ID: 15995499 [TBL] [Abstract][Full Text] [Related]
18. Trends in Oral Antibiotic, Proton Pump Inhibitor, and Histamine 2 Receptor Blocker Prescription Patterns for Children Compared With Adults: Implications for Clostridium difficile Infection in the Community. Faden HS; Ma CX Clin Pediatr (Phila); 2016 Jul; 55(8):712-6. PubMed ID: 26350427 [TBL] [Abstract][Full Text] [Related]
19. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease. Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741 [TBL] [Abstract][Full Text] [Related]
20. Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals. Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR J Pediatr; 2016 Jul; 174():63-70.e3. PubMed ID: 27131401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]